Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,032.50    -10.00 (-0.96%)
Bid:
1,033.50
Ask:
1,035.00
Spread: 1.50 (0.145%)
Market Cap: £5.05b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading Update

12 Feb 2020 07:00

RNS Number : 6891C
Babcock International Group PLC
12 February 2020
 

12 February 2020

 

Babcock International Group PLC (Babcock or the Group) Trading update

 

Babcock, the aerospace and defence company, is issuing this update following trading in the first nine months of the financial year.

 

Expectations for this financial year

Our expectations for underlying earnings per share are in line with current consensus expectations1. We update our detailed guidance previously set out in November 2019.

 

Previous guidance

New guidance

Underlying revenue

Around £4.9 billion

Around £4.9 billion

Underlying operating profit2

£540 million to £560 million

Around £540 million

Free cash flow

Over £250 million

Over £250 million

Net debt

Reduced

Reduced

 

In response to current trading in Aviation, as explained further below, we are implementing improvement and restructuring programmes to ensure we remain on track to deliver for the medium term. We will also write down assets and leases in our oil and gas business. We expect to incur an exceptional charge related to these issues of around £85 million, predominantly in oil and gas.

 

Trading update

Our Marine sector continues to perform well and exceed expectations. Strong revenue growth has been helped by warship support activity in the UK and Australia and continued high growth in our technology businesses. Demand for complex liquid gas transportation systems has been higher than expected.

 

In Nuclear, revenue growth in UK defence continues in line with our expectations, underpinned by ongoing submarine engineering support work. The civil nuclear market remains subdued and we continue to progress closer integration of our nuclear engineering businesses.

 

Land continues to trade well, with underlying revenue growth supported by defence revenues and strong trading in South Africa.

 

Trading in our Aviation business is mixed with good performances across our UK and international defence businesses offset by continued challenges in Southern Europe and in our oil and gas business. As a result, we have lowered our expectations for Aviation for this financial year as reflected above.

 

As flagged in November, there have been delays in the award of new contracts for aerial emergency services in Italy and Spain. Since then, we have won or been selected as preferred bidder for contracts worth around £600 million but the delays have pushed revenue into future periods.

 

Oil and gas continues to be a tough market. The three large providers of helicopter services who operate worldwide in oil and gas have all emerged from Chapter 11 bankruptcy protection with reduced debt and written-down assets. This has effectively reset global market pricing levels, forcing us to respond quickly to remain competitive. We will also exit our oil and gas businesses in Ghana and Congo.

 

Order book and pipeline

The Group continued to win work across all sectors in the period, with win rates in line with our targets. Our combined order book and pipeline remains at the record level of £34 billion, with an order book of £18 billion and pipeline of £16 billion.

 

 

For further information please contact:

Babcock International Group PLC

Simon McGough

Kate Hill

Director of Investor Relations

Group Director of Communications

Tel: +44 (0)20 3823 5592

Tel: +44 (0)20 7355 5312

FTI Consulting

Andrew Lorenz / Nick Hasell / Alex Le May

Tel: +44 (0)20 3727 1340

 

 

Conference call

A conference call for analysts and investors will be held at 08:00 (UK time) this morning, hosted by Archie Bethel (Chief Executive) and Franco Martinelli (Group Finance Director).

 

Webcast link:

www.babcockinternational.com/investors/results-and-presentations 

 

Live call:

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Replay (available for 7 days):

Standard International Access

+44 (0) 20 8196 1480

UK Toll Free

0800 633 8453

PIN

3144160#

 

A transcript will be made available at www.babcockinternational.com/investors.

 

 

Notes

1. FY20 consensus for underlying EPS: 71.4p (Vuma, 19 December 2019), 71.1p (Bloomberg, 11 February 2020), 71.1p (Reuters, 11 February 2020)

2. Guidance set in May 2019 was for underlying operating profit in the range of £515 million to £535 million on an IAS 17 basis. Guidance was updated in November 2019 on an IFRS 16 basis, which added around £25 million to operating profit

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFIFUFESSEDE
Date   Source Headline
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.